@article{JTD9033,
author = {Takashi Murashita},
title = {The role of coronary artery bypass grafting in patients with ischemic cardiomyopathy in the current era},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {9},
year = {2016},
keywords = {},
abstract = {Coronary artery bypass grafting (CABG) is widely accepted as the preferred treatment for left main or multi-vessel coronary artery disease, but benefit of CABG in patients with left ventricular dysfunction is not established. The most recent American College of Cardiology Foundation/American Heart Association 2013 Heart Failure Clinical Practice Guidelines state that either CABG or medical therapy is reasonable treatment for patients with severe left ventricular dysfunction (ejection fraction },
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/9033}
}